HCV inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8518874
APP PUB NO 20100266537A1
SERIAL NO

12605271

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
QUEST DIAGNOSTICS INVESTMENTS LLC500 PLAZA DRIVE C/O JOEL S WHITE SECAUCUS NJ 07094

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Graupe, Michael Pacifica, US 108 1312
Link, John O San Francisco, US 143 1969
Venkataramani, Chandrasekar Redwood City, US 70 780

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 27, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00